Investors of PepGen Inc. Offered Chance to Lead Class Action Lawsuit

Opportunity for Investors

On June 17, 2025, the Rosen Law Firm, a prominent advocate for investor rights, revealed an important legal initiative for those who invested in PepGen Inc. (NASDAQ: PEPG). A class action lawsuit has been initiated on behalf of all individuals who purchased PepGen securities between March 7, 2024, and March 3, 2025. This strategic legal action offers investors a pathway to seek compensation for potential damages suffered due to misleading statements made by the company's management.

Background of the Case

The class action lawsuit claims that the defendants made several false and misleading claims throughout the class period. Specifically, it is alleged that PepGen's management misrepresented the effectiveness and safety of their drug, PGN-EDO51, while failing to disclose crucial information regarding the CONNECT2 clinical trial deficiencies. This lack of transparency is believed to have led investors to believe in inflated commercial and regulatory prospects for PepGen, which ultimately were not accurate.

When the truth emerged—revealing that PGN-EDO51's clinical and regulatory outlook was not as promising as previously suggested—investors began to suffer losses. The Rosen Law Firm is urging affected investors to take action, as they may be entitled to compensation without upfront costs, thanks to a contingency fee arrangement that they typically offer in such cases.

Joining the Class Action

If you are a PepGen investor during the Class Period and are considering participating in the class action, you are encouraged to act swiftly. The Rosen Law Firm stresses the importance of moving quickly, as applications to be the lead plaintiff must be submitted to the court by August 8, 2025. The lead plaintiff serves a significant role as they guide the direction of the litigation on behalf of the other class members.

For those interested, further information can be obtained through a designated website or by contacting Phillip Kim, Esq. via phone or email as listed in their press release.

Importance of Experienced Counsel

The Rosen Law Firm not only brings years of experience to the table but a proven track record in handling similar cases. They have achieved noteworthy results for their clients, including the largest securities class action settlement involving a Chinese company at that time. Their dedication to representing the interests of investors has resulted in securing vast amounts of recoveries—over $438 million in 2019 alone.

Investors are encouraged to choose legal counsel wisely, favoring firms like Rosen Law that have demonstrated success and recognition in the field of securities litigation.

Conclusion

This legal action represents a significant development for PEPG investors seeking justice and compensation for alleged securities fraud. With established legal guidance and a collective move towards accountability, investors play a vital role in this unfolding scenario. If you believe you have been affected by the alleged misleading practices of PepGen Inc., consider joining the class action to protect your rights and interests effectively. Updates will be made available through various social media channels, allowing investors to stay informed on the outcome of this lawsuit.